In Regard to Kimura et al.

Published on Jun 1, 2021in International Journal of Radiation Oncology Biology Physics5.859
· DOI :10.1016/J.IJROBP.2020.12.056
Zhaonan Li7
Estimated H-index: 7
(Zhengzhou University),
Dechao Jiao9
Estimated H-index: 9
(Zhengzhou University),
Xinwei Han21
Estimated H-index: 21
(Zhengzhou University)
#1Tomoki Kimura (Hiroshima University)H-Index: 18
#2Atsuya TakedaH-Index: 27
Last. Yasushi Nagata (Hiroshima University)H-Index: 47
view all 9 authors...
Abstract Purpose Through this multi-institutional study, we aimed to retrospectively evaluate the safety and efficacy of repeated stereotactic body radiation therapy (SBRT) for intra-hepatic recurrent hepatocellular carcinoma (HCC). Materials and methods Between 2005 and 2017, 709 patients with 835 HCCs underwent SBRT; those treated with repeated SBRT were eligible. The median prescribed dose was 40 Gy in 5 fractions. Results Eighty-one patients with 189 tumors underwent repeated SBRT (≥2 course...
4 CitationsSource
#1Katerina Mastrocostas (Women's College Hospital)H-Index: 1
#2Hyun-Jung Jang (Women's College Hospital)H-Index: 7
Last. Tae Kyoung Kim (Women's College Hospital)H-Index: 63
view all 7 authors...
Stereotactic body radiation therapy (SBRT) has increased utility in the management of hepatocellular carcinoma (HCC) ranging from local therapy in early-stage HCC not suitable for other focal therapies to end-stage HCC. As the indications for the use of SBRT in HCC expand, diagnostic imaging is being increasingly used to assess response to treatment. The imaging features of tumor response do not parallel those of other focal therapies such as radiofrequency ablation or trans-arterial chemoemboli...
7 CitationsSource
#1Mustafa M. Haddad (Mayo Clinic)H-Index: 6
#2Kenneth W. Merrell (Mayo Clinic)H-Index: 11
Last. Sudhakar K. Venkatesh (Mayo Clinic)H-Index: 41
view all 8 authors...
Stereotactic body radiation therapy (SBRT) is a noninvasive treatment technique for selected patients with primary liver tumors and liver-confined oligometastatic disease. Recently, SBRT has emerged as an alternative treatment option in non-surgical candidates and in whom percutaneous treatment methods are not possible or contraindicated. The experience with SBRT continues to grow. There are currently no imaging guidelines for assessment of tumor response and follow-up schedule following SBRT. S...
19 CitationsSource
#1Olga R. Brook (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 20
#2Eavan Thornton (Beaumont Hospital)H-Index: 9
Last. Bettina Siewert (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 31
view all 9 authors...
Purpose. To study radiological response to stereotactic radiotherapy for focal liver tumors. Materials and Methods. In this IRB-approved, HIPAA-compliant study CTs of 68 consecutive patients who underwent stereotactic radiotherapy for liver tumors between 01/2006 and 01/2010 were retrospectively reviewed. Two independent reviewers evaluated lesion volume and enhancement pattern of the lesion and of juxtaposed liver parenchyma. Results. 36 subjects with hepatocellular carcinoma (HCC), 25 with liv...
6 CitationsSource
#1Muneeb Ahmed (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 42
#2Luigi SolbiatiH-Index: 64
Last. S. Nahum GoldbergH-Index: 81
view all 35 authors...
The main objective of this document is to improve precision in communication in the field of image-guided tumor ablation that leads to more accurate comparison of technologies and results and ultimately to improved patient outcomes.
608 CitationsSource
Cited By1
#1Tomoki Kimura (Hiroshima University)H-Index: 18
#2Atsuya TakedaH-Index: 27
Last. Yuichiro TsurugaiH-Index: 6
view all 3 authors...